Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of 4‑week‑old refrigerated Letibotulinumtoxin A for lateral canthal lines
TCTR20240817004Phase 3Completed
- Start
- Nov 2023
- Countries
- 1
01
Overview
Phase 3 trial in lateral canthal rhytides, sponsored by none. Started Nov 2023; status: completed.
02
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on TCTR20240817004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240817004.